For many patients, this leads to: reduced hunger fewer cravings feeling full longer improved blood sugar regulation easier calorie reduction without constant hunger Originally developed to treat type 2 diabetes, several GLP-1 medications are now FDA-approved for chronic weight management, while others continue to be studied in clinical trials
Long-term maintenance data Some TRIUMPH trials include extensions evaluating maintenance dosing
Pricing, Access, and Support: PlexusDx Makes GLP-1 Affordable PlexusDx breaks down barriers to GLP-1 access by offering treatment without requiring insurance, membership fees, or long-term contracts
However, its side effects can differ slightly: Gastrointestinal Discomfort: Nausea, bloating, and stomach pain are common, especially in the first few weeks
These proportions mirror what happens with diet-induced weight loss, but the absolute numbers are far larger because tirzepatide produces far more total weight loss